Speech Outcome After Partial Adenoidectomy in Patients With Risk of Hypernasality

Hypernasality Clinical Trial

Official title:

Speech Outcome After Partial Adenoidectomy in Patients With Risk of Hypernasality

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05273853
• Other study ID #: DAHAllah
• Status: Recruiting
• Phase: N/A
• Start date: February 4, 2022
• Est. completion date: December 1, 2022

Study information

• Verified date: March 2022
• Source: Sohag University
• Contact: Dina A Hasb Allah, Resident
• Phone: +201286000163
• Email: dina_ewaida_post[@]med.sohag.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Adenoid hypertrophy is a common cause of airway obstruction in children; it may lead to mouth breathing, nasal discharge, snoring, sleep apnea, and hyponasal speech.

Description:

Adenoid hypertrophy is a common cause of airway obstruction in children; it may lead to mouth breathing, nasal discharge, snoring, sleep apnea, and hyponasal speech. It also contributes to the pathogenesis of rhinosinusitis and recurrent otitis media. However, the adenoid lies in the posterior nasopharyngeal wall and may act as a pad against the palate facilitating velopharyngeal closure, especially in patients with palatal abnormalities; Its presence can compensate for a short or poorly mobile palate. Following adenoidectomy, compensation is eliminated and velopharyngeal insufficiency (VPI) may result. Therefore, patients with palatal abnormalities (such as poor palatal mobility, short palate, occult submucosal cleft palate, scarred palate after previous tonsillectomy, and repaired cleft palate) are at high risk to develop hypernasality after complete adenoidectomy, and in such situations conservative or partial adenoidectomy is performed

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 1, 2022
• Est. primary completion date: August 4, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Year to 12 Years

Eligibility

Inclusion Criteria:

1. Patient with symptoms of adenoid hypertrophy.

2. High risk to VPI:

1. Short palate.

2. Scarred palate after previous tonsillectomy.

3. Occult submucous cleft.

4. Deep pharynx.

5. Repaired cleft palate.

Exclusion Criteria:

• Any neurological deficit, muscular disorder or structural defects of the palate (as cleft palate).

Related Conditions & MeSH terms

• Hypernasality

Intervention

Procedure:
• Partial Adenoidectomy
Partial removal of adenoid

Locations

Country	Name	City	State
Egypt	Sohag Faculty of Medicine	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Rowe MR, D'Antonio LL. Velopharyngeal dysfunction: evolving developments in evaluation. Curr Opin Otolaryngol Head Neck Surg. 2005 Dec;13(6):366-70. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Speech Outcome	Change of a degree of Nasal Tone during speech	1 month after operation
Primary	Speech Outcome	Change of a degree of Nasal Tone during speech	3 months after operation